POAI - Predictive Oncology Inc.
1.01
-0.020 -1.980%
Share volume: 41,074
Last Updated: 05-07-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$1.03
-0.02
-0.02%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-14-2024 | 08-10-2023 | 11-13-2023 | 11-12-2024 | 05-14-2024 | 08-13-2024 | 11-12-2024 | |
| Total revenue | 239.895 K | 490.110 K | 676.626 K | 335.032 K | 419.646 K | 278.722 K | 345.686 K | |
| Cost of revenue | 120.139 K | 159.761 K | 97.868 K | 247.956 K | 187.415 K | 152.968 K | 196.919 K | |
| Gross profit | 119.756 K | 330.349 K | 578.758 K | 87.076 K | 232.231 K | 125.754 K | 148.767 K | |
| 175.85% | 75.20% | -84.95% | 166.70% | -45.85% | 18.30% | |||
| Operating expenses | 3.215 M | 3.698 M | 2.983 M | 3.218 M | 3.729 M | 3.031 M | 2.216 M | |
| Selling general and admin | 3.215 M | 3.698 M | 2.983 M | 3.218 M | 3.729 M | 3.031 M | 2.216 M | |
| Research and development | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total expenses | 3.585 M | 4.290 M | 3.318 M | 3.593 M | 4.469 M | 3.315 M | 2.463 M | |
| 19.66% | -22.66% | 8.30% | 24.38% | -25.82% | -25.71% | |||
| Operating income | -3.465 M | -3.959 M | -2.739 M | -3.506 M | -4.237 M | -3.189 M | -2.314 M | |
| Ebit | -3.422 M | -3.923 M | -2.736 M | -3.410 M | -4.217 M | -3.179 M | -2.278 M | |
| Pretax income | -3.422 M | -3.923 M | -2.736 M | -3.410 M | -4.217 M | -3.179 M | -2.278 M | |
| 14.66% | -30.28% | 24.67% | 23.66% | -24.61% | -28.36% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -3.422 M | -3.923 M | -3.163 M | -3.475 M | -4.219 M | -3.181 M | -3.095 M | |
| -14.66% | 19.37% | -9.86% | -21.39% | 24.59% | 2.72% |
